Menstruation, a natural biological process affecting millions, has become a flashpoint in political discourse. Lawmakers are clashing over access to products, safety standards, education, and broader reproductive rights, with implications for gender equity and public health.
The Growing Push for Menstrual Equity
Efforts to address period poverty—the inability to afford or access menstrual products—have gained traction through federal and state initiatives. Legislation aims to provide free distribution in schools, workplaces, and low-income communities, recognizing that lack of access hinders education and economic participation.
The Menstrual Equity For All Act of 2025 seeks to boost availability for those with limited means by funding distributions, outreach, and community programs. This bill emphasizes reducing unmet needs among low-income individuals through targeted support.
- Free products in public facilities like schools and community centers.
- Community outreach to connect families with existing programs.
- Enhanced affordability for low-income adults.
States like California have led with measures such as eliminating sales tax on menstrual items and mandating free pads in schools, building a foundation for national reform.
Challenging Stigma Through Awareness and Recognition
Cultural taboos around menstruation perpetuate shame, limiting access to education, work, and healthcare. A congressional resolution highlights how stigma affects dignity, school attendance, and mental health, calling for a National Menstrual Health Awareness Month.
This initiative promotes normalizing periods as a healthy process and supports education on management, including conditions like endometriosis, fibroids, and polycystic ovary syndrome (PCOS). It stresses the need for safe sanitation facilities and research into understudied women’s health issues.
Menstrual health disparities impact economic opportunities; investing in it advances gender equality.
Globally, 500 million people lack basic menstrual hygiene resources, underscoring the urgency for policy action that ties menstruation to human rights and security.
Safety Concerns and Regulatory Scrutiny
Recent investigations into menstrual product safety have spotlighted potential contaminants like PFAS (per- and polyfluoroalkyl substances), prompting bans and testing requirements. California’s AB 2515 prohibits intentional PFAS addition and mandates standardized testing by 2027.
The FDA’s 2024 probe concluded no immediate hazards but fueled ongoing state-level precautions. Manufacturers argue trace contamination from supply chains is unavoidable, yet advocates prioritize consumer protection amid uncertainty.
| State Action | Key Provisions | Impact |
|---|---|---|
| California AB 2515 (2024) | Bans PFAS; DTSC testing standards | Improved product safety thresholds |
| SB 92 (2019) | Tax exemption on products | Lower costs for consumers |
| AB 10 (2017) | Free products in schools | Better student access |
These steps reflect ‘lived experience’ driving policy, as underrepresented voices push for transparency and health safeguards.
Broader Women’s Health Policy in Flux
Menstrual issues intersect with larger reproductive health battles. Projections for 2026 warn of setbacks from potential Affordable Care Act rollbacks, affecting 11.2 million women reliant on its protections for preventive care like contraceptives and screenings.
Defunding Planned Parenthood has closed clinics, exacerbating ‘medical deserts’ and unplanned pregnancies. Medication abortion faces renewed FDA scrutiny on mifepristone, despite its safety record.
Conversely, menopause—a phase linked to menstrual cessation—is seeing progress. States like New Jersey mandate insurance coverage for treatments, while others advance education and anti-discrimination measures.
Global Perspectives on Menstrual Health Management
Internationally, menstrual health and hygiene (MHM) is framed as a human security issue, impacting economic stability, personal safety, and health in crises. Policies remain limited, but initiatives recommend prioritization in humanitarian aid and development.
The Wilson Center urges integrating MHM into national strategies, addressing gaps in fragile settings where access is dire.
Health Equity and Economic Implications
Period poverty contributes to absenteeism: girls miss school, women skip work, perpetuating cycles of disadvantage. Physicians advocate free distribution in public spaces to promote equity.
KFF highlights how policies shape women’s health, from maternal care to chronic conditions, disproportionately burdening underserved groups.
The Society for Women’s Health Research’s 2025-2026 agenda pushes bipartisan bills on endometriosis, maternal mortality, and menopause, signaling cross-aisle potential.
Overcoming Barriers: Education and Infrastructure
Key to progress is infrastructure: private sanitation, water access, and education. Daily, 6,000 U.S. women enter menopause, yet research lags on related conditions.
Workplace policies must evolve to support menstruation without stigma, ensuring safe conditions and product availability.
Frequently Asked Questions (FAQs)
What is period poverty?
Period poverty refers to the lack of access to menstrual products, sanitation, or education due to financial or systemic barriers, affecting health and opportunities.
How do politics impact menstrual product access?
Federal bills like the Menstrual Equity For All Act fund distributions, while state taxes and school mandates reduce costs; threats like ACA changes could reverse gains.
Are menstrual products safe from contaminants?
FDA found no major risks in 2024, but states ban PFAS and require testing due to trace concerns in supply chains.
Why recognize a National Menstrual Health Awareness Month?
To normalize periods, combat stigma, boost education on conditions like PCOS, and improve access to care and facilities.
What role does menopause play in this discussion?
As the end of menstruation, it’s gaining policy focus with insurance mandates and research pushes amid broader reproductive shifts.
Looking Ahead: Pathways to Equity
Momentum builds despite divides. Bipartisan resolutions, state innovations, and global advocacy signal potential for comprehensive reform. Sustained investment in research, access, and destigmatization can transform menstrual health into a cornerstone of equity.
Challenges persist—funding cuts, regulatory hurdles, cultural biases—but evidence shows policy changes yield measurable benefits in health, education, and economy.
References
- Predictions for Women’s Health in 2026: A Dark Year, With a Few … — Ms. Magazine. 2026-01-12. https://msmagazine.com/2026/01/12/women-health-policy-2026-trump-affordable-care-act-planned-parenthood-pregnancy-federal-menopause/
- H.Res.372 – 119th Congress (2025-2026): Recognizing the impact … — Congress.gov. 2025. https://www.congress.gov/bill/119th-congress/house-resolution/372/text
- Lived experience drives push for menstrual product safety — Capitol Weekly. 2024. https://capitolweekly.net/lived-experience-drives-push-for-menstrual-product-safety/
- 119th Congress (2025-2026): Menstrual Equity For All Act of 2025 — Congress.gov. 2025. https://www.congress.gov/bill/119th-congress/house-bill/3644/text
- Global Health & Gender Policy Brief: Menstrual … – Wilson Center — Wilson Center. N/A. https://www.wilsoncenter.org/publication/global-health-gender-policy-brief-menstrual-health-and-management
- Health Policy Issues in Women’s Health – KFF — KFF. N/A. https://kff.org/womens-health-policy/health-policy-101-health-policy-issues-in-womens-health/
- 2025-2026 Women’s Health Policy Agenda — SWHR. 2025-04. https://swhr.org/wp-content/uploads/2025/04/SWHR2025PolicyAgenda.pdf
